SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jiin-Ling Jiang, Shu-Fen Lo, Sheng-Tzung Tsai, Shin-Yuan Chen, A systematic review of the impact of subthalamic nucleus stimulation on the quality of life of patients with Parkinson's disease, Tzu Chi Medical Journal, 2014, 26, 1, 15

    CrossRef

  2. 2
    Gordon W. Duncan, Tien K. Khoo, Alison J. Yarnall, John T. O'Brien, Shirley Y. Coleman, David J. Brooks, Roger A. Barker, David J. Burn, Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms, Movement Disorders, 2014, 29, 2
  3. 3
    Richard Dodel, Bengt Jönsson, Jens Peter Reese, Yaroslav Winter, Pablo Martinez-Martin, Robert Holloway, Cristina Sampaio, Evžen Růžička, Graeme Hawthorne, Wolfgang Oertel, Werner Poewe, Glenn Stebbins, Oliver Rascol, Christopher G. Goetz, Anette Schrag, Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease, Movement Disorders, 2014, 29, 2
  4. 4
    J.G. Nutt, A.D. Siderowf, M. Guttman, P.N. Schmidt, J.I. Zamudio, S.S. Wu, M.S. Okun, T. Simuni, S.A. Parashos, N.A. Dahodwala, T.L. Davis, N. Giladi, T. Gurevich, R.A. Hauser, J. Jankovic, K.E. Lyons, L. Marsh, J.M. Miyasaki, J.C. Morgan, A.J. Santiago, D. Tarsy, Z. Mari, I.A. Malaty, E.C. Nelson, Mobility, mood and site of care impact health related quality of life in Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 3, 274

    CrossRef

  5. 5
    Pablo Martinez-Martin, Nonmotor symptoms and health-related quality of life in early Parkinson's disease, Movement Disorders, 2014, 29, 2
  6. 6
    Hanen Borchani, Concha Bielza, Pablo Martinez-Martin, Pedro Larrañaga, PREDICTING THE EQ-5D FROM THE PARKINSON'S DISEASE QUESTIONNAIRE PDQ-8 USING MULTI-DIMENSIONAL BAYESIAN NETWORK CLASSIFIERS, Biomedical Engineering: Applications, Basis and Communications, 2014, 26, 01, 1450015

    CrossRef

  7. 7
    Jane Simpson, Godwin Lekwuwa, Trevor Crawford, Predictors of quality of life in people with Parkinson’s disease: evidence for both domain specific and general relationships, Disability and Rehabilitation, 2014, 1

    CrossRef

  8. 8
    Linda Dauwerse, Annette Hendrikx, Karen Schipper, Chris Struiksma, Tineke A. Abma, Quality-of-life of patients with Parkinson’s disease, Brain Injury, 2014, 28, 10, 1342

    CrossRef

  9. 9
    P. Martínez-Martín, C. Rodríguez-Blázquez, M. J. Forjaz, M. Álvarez-Sánchez, T. Arakaki, A. Bergareche-Yarza, A. Chade, N. Garretto, O. Gershanik, M. M. Kurtis, J. C. Martínez-Castrillo, A. Mendoza-Rodríguez, H. P. Moore, M. Rodríguez-Violante, C. Singer, B. C. Tilley, J. Huang, G. T. Stebbins, C. G. Goetz, Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients , European Journal of Neurology, 2014, 21, 3
  10. 10
    Fabrizio Stocchi, Paola Stirpe, The relevance of dopaminergic level in nocturnal disability in Parkinson’s disease: implications of continuous dopaminergic stimulation at night to treat the symptoms, Journal of Neural Transmission, 2014, 121, S1, 79

    CrossRef

  11. 11
    Miguel Ángel García-Gordillo, Borja del Pozo-Cruz, José Carmelo Adsuar, Fernando Ignacio Sánchez-Martínez, José María Abellán-Perpiñán, Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson’s disease population sample, Quality of Life Research, 2014, 23, 4, 1315

    CrossRef

  12. 12
    J. Kulisevsky, M.R. Luquin, J.M. Arbelo, J.A. Burguera, F. Carrillo, A. Castro, J. Chacón, P.J. García-Ruiz, E. Lezcano, P. Mir, J.C. Martinez-Castrillo, I. Martínez-Torres, V. Puente, A. Sesar, F. Valldeoriola-Serra, R. Yañez, Advanced Parkinson's disease: Clinical characteristics and treatment (part 1), Neurología (English Edition), 2013, 28, 8, 503

    CrossRef

  13. 13
    Sze-Ee Soh, Jennifer L. McGinley, Jennifer J. Watts, Robert Iansek, Anna T. Murphy, Hylton B. Menz, Frances Huxham, Meg E. Morris, Determinants of health-related quality of life in people with Parkinson’s disease: a path analysis, Quality of Life Research, 2013, 22, 7, 1543

    CrossRef

  14. 14
    J. Kulisevsky, M.R. Luquin, J.M. Arbelo, J.A. Burguera, F. Carrillo, A. Castro, J. Chacón, P.J. García-Ruiz, E. Lezcano, P. Mir, J.C. Martinez-Castrillo, I. Martínez-Torres, V. Puente, A. Sesar, F. Valldeoriola-Serra, R. Yañez, Enfermedad de Parkinson avanzada. Características clínicas y tratamiento (parte I), Neurología, 2013, 28, 8, 503

    CrossRef

  15. 15
    Bernd Müller, Jörg Assmus, Karen Herlofson, Jan Petter Larsen, Ole-Bjørn Tysnes, Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 11, 1027

    CrossRef

  16. 16
    Pablo Martinez-Martin, Instruments for holistic assessment of Parkinson’s disease, Journal of Neural Transmission, 2013, 120, 4, 559

    CrossRef

  17. 17
    R. Edragas, C. Guiraudie, E. Bouron, C. Souchet, M. Soubeyran, P. René-Corail, Intérêt de mettre en œuvre un programme en éducation thérapeutique du patient parkinsonien ? Phase expérimentale d’un programme en Martinique, La Lettre de médecine physique et de réadaptation, 2013, 29, 3, 145

    CrossRef

  18. 18
    W.M.M. Schuepbach, J. Rau, K. Knudsen, J. Volkmann, P. Krack, L. Timmermann, T.D. Hälbig, H. Hesekamp, S.M. Navarro, N. Meier, D. Falk, M. Mehdorn, S. Paschen, M. Maarouf, M.T. Barbe, G.R. Fink, A. Kupsch, D. Gruber, G.-H. Schneider, E. Seigneuret, A. Kistner, P. Chaynes, F. Ory-Magne, C. Brefel Courbon, J. Vesper, A. Schnitzler, L. Wojtecki, J.-L. Houeto, B. Bataille, D. Maltête, P. Damier, S. Raoul, F. Sixel-Doering, D. Hellwig, A. Gharabaghi, R. Krüger, M.O. Pinsker, F. Amtage, J.-M. Régis, T. Witjas, S. Thobois, P. Mertens, M. Kloss, A. Hartmann, W.H. Oertel, B. Post, H. Speelman, Y. Agid, C. Schade-Brittinger, G. Deuschl, Neurostimulation for Parkinson's Disease with Early Motor Complications, New England Journal of Medicine, 2013, 368, 7, 610

    CrossRef

  19. 19
    Kieran C. Breen, Gerda Drutyte, Non-motor symptoms of Parkinson’s disease: the patient’s perspective, Journal of Neural Transmission, 2013, 120, 4, 531

    CrossRef

  20. 20
    Victor W. Sung, Anthony P. Nicholas, Nonmotor Symptoms in Parkinson's Disease, Neurologic Clinics, 2013, 31, 3, S1

    CrossRef

  21. 21
    Günther Deuschl, Michael Schüpbach, Karina Knudsen, Marcus O. Pinsker, Philippe Cornu, Jörn Rau, Yves Agid, Carmen Schade-Brittinger, Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: Concept and standards of the EARLYSTIM-study, Parkinsonism & Related Disorders, 2013, 19, 1, 56

    CrossRef

  22. 22
    Günther Deuschl, Steffen Paschen, Karsten Witt, Brain Stimulation, 2013,

    CrossRef

  23. 23
    Santiago Perez-Lloret, María Verónica Rey, Estelle Dellapina, Jean Pellaprat, Christine Brefel-Courbon, Olivier Rascol, Emerging analgesic drugs for Parkinson's disease, Expert Opinion on Emerging Drugs, 2012, 17, 2, 157

    CrossRef

  24. 24
    D. Morley, S. Dummett, M. Peters, L. Kelly, P. Hewitson, J. Dawson, R. Fitzpatrick, C. Jenkinson, Factors Influencing Quality of Life in Caregivers of People with Parkinson's Disease and Implications for Clinical Guidelines, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  25. 25
    Hanen Borchani, Concha Bielza, Pablo Martı´nez-Martı´n, Pedro Larrañaga, Markov blanket-based approach for learning multi-dimensional Bayesian network classifiers: An application to predict the European Quality of Life-5 Dimensions (EQ-5D) from the 39-item Parkinson’s Disease Questionnaire (PDQ-39), Journal of Biomedical Informatics, 2012, 45, 6, 1175

    CrossRef

  26. 26
    Sotirios A Parashos, Multidisciplinary treatment of Parkinson’s disease: current state and future directions, Clinical Practice, 2012, 9, 2, 189

    CrossRef

  27. 27
    Themis P. Exarchos, Alexandros T. Tzallas, Dina Baga, Dimitra Chaloglou, Dimitrios I. Fotiadis, Sofia Tsouli, Maria Diakou, Spyros Konitsiotis, Using partial decision trees to predict Parkinson’s symptoms: A new approach for diagnosis and therapy in patients suffering from Parkinson’s disease, Computers in Biology and Medicine, 2012, 42, 2, 195

    CrossRef